Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells

Citation
K. Inoki et al., Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells, KIDNEY INT, 58, 2000, pp. S76-S80
Citations number
37
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
KIDNEY INTERNATIONAL
ISSN journal
00852538 → ACNP
Volume
58
Year of publication
2000
Supplement
77
Pages
S76 - S80
Database
ISI
SICI code
0085-2538(200009)58:<S76:ROMPKA>2.0.ZU;2-H
Abstract
Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine th at regulates cell proliferation, differentiation, and production of extrace llular matrix proteins in various types of cells including mesangial cells. Although TGF-beta has been also known as an important player in the pathog enesis of various fibrotic diseases including glomerulosclerosis, signal-tr ansduction cascades of TGF-beta have remained to be clarified. However, eme rging evidence indicates that TGF-beta can activate various signal transduc tion cascades such as Smad proteins and mitogen-activated protein kinases ( MAPKs) in many types of cells. Here, we examine the role of MAPKs in TGF-be ta-induced gene expression of extracellular matrix proteins in mesangial ce lls. TGF-beta increases extracellular signal-regulated kinase (ERK) activit y, one of the MAPKs, and the expression of fibronectin mRNA and protein in rat mesangial cells. Furthermore, PD98059, a specific inhibitor of MAPK/ERK kinase (MEK), can inhibit this TGF-beta-induced fibronectin expression. Th ese data suggest that MAPKs play an important role in TGF-beta-mediated ext racellular matrix production in mesangial cells.